Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Batroxobin injection for progressing ischemic stroke
ChiCTR-OCH-14004480Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Harbin Medical University
- Start
- May 2014
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of batroxobin in ischemic stroke and stroke, sponsored by The First Affiliated Hospital of Harbin Medical University. Primary endpoints: National Institutes of Health Stroke Scale (NIHSS), Barthel Index and 1 more. Started May 2014; status: recruiting.
02
Drugs
batroxobin
03
Conditions
ischemic strokestroke
Beyond the preview
Go deeper on ChiCTR-OCH-14004480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OCH-14004480.